Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protocol T: Aflibercept, Bevacizumab, and Ranibizumab for DME
NCT01627249Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Engineered Antibody Formats, Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of aflibercept, bevacizumab in diabetic macular edema (DME), sponsored by Jaeb Center for Health Research. Started Aug 2012; status: completed.
02
Drugs
afliberceptbevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01627249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627249.